In a move to develop more digital health startups and new, breakthrough medical devices, Accelmed just launched a new fund of nearly $100 million for investing worldwide. This is the fourth fund from the New York- and Israel-based firm, that will specifically target entrepreneurs who are trying to raise capital for their innovative devices to go through regulatory processes—clinical (and human) trials and FDA approval—while also providing digital health companies with the capital to fund initial stages...
Sorry, you need to subscribe to read this article.
If you would like to access this article, please subscribe below.
Premium subscribers receive complete access to our site content which includes market research and insights as well as coverage of the most important news, issues and events related to the healthcare technology industry.